Back to top
more

Becton, Dickinson and Company (BDX)

(Real Time Quote from BATS)

$235.73 USD

235.73
468,104

+4.09 (1.77%)

Updated Nov 11, 2024 11:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Cigna to Take Over Express Scripts (ESRX) for $67 Billion

Per a definitive agreement, Cigna will take over Express Scripts (ESRX) in a cash-and-stock transaction worth $67 billion.

    Becton, Dickinson (BDX) Down 1.3% Since Last Earnings Report

    Becton, Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4

      Strong performance at Dental & Healthcare Consumables segment drives DENTSPLY's (XRAY) Q4 sales.

        Patterson Companies (PDCO) Misses on Q3 Earnings, Cuts View

        Lower sales and gross-margin compression mars Patterson Companies' (PDCO) results in Q3.

          Express Scripts (ESRX) Q4 Earnings Top, Long-Term View Solid

          Express Scripts' (ESRX) fourth-quarter 2017 results benefit from rise in patient claims and strong customer retention.

            Mark Vickery headshot

            MedTech's Long-Term Prospects Outweigh Near-Term Risks

            A growing prevalence of minimally invasive surgeries, rising demand for liquid biopsy tests, use of IT for ensuring quick and improved patient care and the shift of the payment system to a value-based model are among the updates.

              STERIS Focuses on Expanding Core Business, Competition Rife

              STERIS (STE) pursues six acquisitions in the first nine months of fiscal 2018.

                Here's Why You Should Invest in LabCorp (LH) Stock Right Now

                Strong guidance and Covance Drug Development's sturdy growth raise investors optimism on LabCorp (LH).

                  Henry Schein (HSIC) Q4 Earnings in Line, 2018 View Upbeat

                  Henry Schein's (HSIC) strong share gains in the North American and overseas markets along with solid revenues raise optimism.

                    AmerisourceBergen (ABC) Jumps: Stock Rises 9.3%

                    AmerisourceBergen (ABC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

                      GNC Holdings to Boost International Business With New Deals

                      GNC Holdings (GNC) adopts initiatives to boost contributions from international business with strong focus on China.

                        GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates

                        Despite sluggish performance by manufacturing/wholesale segments, GNC Holdings (GNC) witnesses revenue growth in Q4.

                          CVS Health (CVS) Q4 Earnings Beat Estimates, '18 View Upbeat

                          A strong Pharmacy Services segment, benefiting from the upside in the specialty services Drives CVS Health's (CVS) topline in Q4.

                            Cardinal Health (CAH) Beats on Q2 Earnings, Raises '18 View

                            Solid performance at the Medical Segment drove Cardinal Health (CAH) in Q2.

                              STERIS (STE) Q3 Earnings Beat & Revenues Miss, Margins Up

                              STERIS (STE) witnesses year-over-year rise in Q3 revenues on favorable underlying market trends along with new product and service offerings.

                                CAH vs. HOLX: Which Will Fare Better This Earnings Season?

                                Here we look at the major factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.

                                  Becton (BDX) Beats on Q1 Earnings and Revenues Estimates

                                  Becton, Dickinson and Company (BDX) delivers strong performance in Q1 on the back strong segmental performance.

                                    Medical Product Stocks' Earnings on Feb 6: BDX, LH & More

                                    Here we take a look at the major factors that are likely to influence the earnings results of a few MedTech bigwigs.

                                      Should You Buy Becton, Dickinson (BDX) Ahead of Earnings?

                                      Becton, Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                                        Quality Systems (QSII) Q3 Earnings in Line, Revenues Beat

                                        Quality Systems (QSII) benefits from solid bookings and acquisitions in Q3.

                                          What's in Store for Becton, Dickinson (BDX) in Q1 Earnings?

                                          Despite solid prospects in the emerging markets, Becton, Dickinson (BDX) is likely to witness sluggishness in BD Medical and BD Life Sciences in Q1.

                                            Becton, Dickinson (BDX), Bard Receive Regulatory Nod in China

                                            Favorable tidings on the regulatory front have boosted Becton, Dickinson and Company (BDX) lately. After the closure of the deal, the company will establish a new business segment.

                                              Becton, Dickinson (BDX) a Step Closer to Bard Acquisition

                                              Becton, Dickinson and Company (BDX) gets FTC's nod for the acquisition of C. R. Bard.

                                                Merit Medical Deserves a Place in Your Portfolio: Here's Why

                                                A slew of bolt-on acquisitions leverages Merit Medical (MMSI) to drive inorganic growth.

                                                  The Zacks Analyst Blog Highlights: Morris, EOG Resources, Becton, Dickinson, Sirius XM and ABB

                                                  The Zacks Analyst Blog Highlights: Morris, EOG Resources, Becton, Dickinson, Sirius XM and ABB